Accepted at 4:50 a.m. Dec, 29, 2023 by Ahmed7
Author: andrewmathias8
Related Note: 1474060036899
Rationale for change

Changed "via" to "by" in "...plasminogen is converted to plasmin *via* tPA." The word "via" implies participation in a pathway, while using "by" more directly signifies that plasminogen is being acted upon by a specific enzyme, rather than being shunted into a pathway.

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step2_v12::#Resources_by_rotation::Surgery::devirgilio_dorian::surgical_cxs #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::03_Antiplatelet,_Anticoagulant,_Thrombolytic_Agents #AK_Step2_v12::#AMBOSS::UQabv4 #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_Hematology #AK_Step1_v12::#AMBOSS::GQaBx4 #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Hematology::Fibrinolytic_System #AK_Other::!AK_UpdateTags::AnKing_Image::Aiman::Fibrinolytic_System #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#AMBOSS::UQabv4 #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::04_Fibrinolysis_and_Inhibitors_of_Hemostasis #AK_Step1_v12::#SketchyPhysiology::10_Hematology::01_Blood_Components_&_Function::01_Coagulation_Cascade #AK_Step2_v12::Original_decks::Dorian::surg::devirgilio::surgical_cxs #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::01_Coagulation_Cascade #AK_Step2_v12::!Shelf::Surgery::no_dupes #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::03_Physiology::05_Coagulation_and_kinin_pathways::*Fibrinolysis #AK_Step1_v12::#Pathoma::04_Hemostasis::03_Other_Disorders_of_Hemostasis #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Step1_v12::^Systems::HemeOnc::Hematology #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::01_Coagulation #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::19_Mixed_platelet_and_coagulation_disorders::*Disorders_of_Fibrinolysis #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::03_HIT_DIC_Disorders_of_Fibrinolysis